These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8142162)

  • 21. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
    Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC
    G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anatomy of missed breast cancers.
    Reintgen D; Berman C; Cox C; Baekey P; Nicosia S; Greenberg H; Bush C; Lyman GH; Clark RA
    Surg Oncol; 1993; 2(1):65-75. PubMed ID: 8252194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis of non-palpable breast lesions: contribution of cytological punctures after stereotaxic localization].
    Meunier M; Le Gal M; Klijanienko J; Vielh P; Neuenschwander S; Durand JC; Asselain B
    J Radiol; 1995 May; 76(5):259-62. PubMed ID: 7783038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stereotaxic cytologic examination of non-palpable lesions of the breast. Experience with 791 consecutive cases].
    Ciatto S; Rosselli del Turco M; Bravetti P; Catarzi S
    Radiol Med; 1991; 81(1-2):65-8. PubMed ID: 2006339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the primary diagnosis with a CAD-system in mammography].
    Malich A; Vogel D; Facius M; Marx C; Freesmeyer MG; Sauner D; Hansch A; Pfleiderer SO; Fleck M; Kaiser WA
    Rofo; 2003 Sep; 175(9):1225-31. PubMed ID: 12964078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient].
    Prats E; Razola P; Sainz JM; Tardín L; Andrés A; Abós MD; García F; Fernández J; Villavieja L; Banzo J
    Rev Esp Med Nucl; 2007; 26(3):153-9. PubMed ID: 17524309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
    Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
    Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammographic needle localisation of impalpable breast lesions.
    O'Laoidhe R; Geraghty JG; Coveney EC; McDermott EW; Hourihane JB; McCabe M; O'Higgins NJ
    Ir Med J; 1992 Jun; 85(2):70-2. PubMed ID: 1628949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nonpalpable lesions of the breast. Diagnostic and therapeutic considerations].
    Bellantone R; Rossi S; Lombardi CP; De Fazio S; Agresti M; Pastore G; Crucitti F
    Minerva Chir; 1994 Apr; 49(4):327-33. PubMed ID: 8072710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of double diagnosis of nonpalpable lesions of the breast.
    Dowlatshahi K; Jokich PM; Kluskens LF; Patel R; Economou SG
    Surg Gynecol Obstet; 1991 Feb; 172(2):121-4. PubMed ID: 1846452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wire-guided biopsies of nonpalpable breast lesions.
    Ahovuo J; Kinnunen J; von Smitten K; Edgren J
    Ann Chir Gynaecol; 1990; 79(2):82-4. PubMed ID: 2386362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric DNA analyses of benign breast lesions detected by screening mammography.
    Stomper PC; DeBloom JR; Budnick RM; Stewart CC
    Clin Cancer Res; 1998 Jun; 4(6):1543-7. PubMed ID: 9626475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
    Garg S; Mohan H; Bal A; Attri AK; Kochhar S
    Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic 14 gauge core-biopsy of the breast: results from 101 patients.
    Frayne J; Sterrett GF; Harvey J; Goodwin P; Townsend J; Ingram D; Parsons RW
    Aust N Z J Surg; 1996 Sep; 66(9):585-91. PubMed ID: 8859155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective comparison of stereotaxic fine-needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities.
    Symmans WF; Weg N; Gross J; Cangiarella JF; Tata M; Mazzo JA; Waisman J
    Cancer; 1999 Mar; 85(5):1119-32. PubMed ID: 10091797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impalpable breast lesions diagnosed by mammography: incidence of histologically confirmed malignancy.
    Rothman LP; Harvald TB; Overgaard H
    Eur J Surg; 1996 Sep; 162(9):691-4. PubMed ID: 8908449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of mammographic appearances after breast fine-needle aspiration.
    Hindle WH; Chen EC
    Am J Obstet Gynecol; 1997 Jun; 176(6):1286-90; discussion 1290-2. PubMed ID: 9215186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography.
    Vizcaíno I; Gadea L; Andreo L; Salas D; Ruiz-Perales F; Cuevas D; Herranz C; Bueno F;
    Radiology; 2001 May; 219(2):475-83. PubMed ID: 11323475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biopsy of the breast for mammographically detected lesions.
    Franceschi D; Crowe J; Zollinger R; Duchesneau R; Shenk R; Stefanek G; Shuck JM
    Surg Gynecol Obstet; 1990 Dec; 171(6):449-55. PubMed ID: 2244276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.